Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price traded up 18.2% on Monday . The stock traded as high as C$0.20 and last traded at C$0.20. 115,700 shares were traded during mid-day trading, a decline of 38% from the average session volume of 187,535 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a quick ratio of 0.84, a current ratio of 0.10 and a debt-to-equity ratio of 4.23. The company has a market cap of C$28.79 million, a PE ratio of -17.77 and a beta of 0.32. The business’s fifty day moving average is C$0.18 and its 200-day moving average is C$0.14.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Calculate Inflation Rate
- Zscaler Will Hit $360 Soon: Here’s the How and Why
- What is the FTSE 100 index?
- 5 Stocks Set to Soar This Summer
- How to Buy Gold Stock and Invest in Gold
- Why SoundHound Could Be a Short Squeeze in the Making
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
